终末期肝病患者的姑息治疗与临终医疗资源利用
本研究利用2009至2013年全国住院患者样本,对失代偿期肝硬化成人临终住院进行横断面观察性分析,发现30.3%接受姑息治疗咨询,咨询比例从2009年18.0%升至2013年36.6%,且姑息治疗与降低10062美元费用相关。
要点
- 终末期肝病临终住院患者中30.3%接受姑息治疗咨询,比例逐年上升。
- 姑息治疗咨询与调整后费用降低10062美元相关。
- 非裔、西班牙裔、亚裔及肝移植候选者接受姑息治疗的可能性较低。
核心结论
- 终末期肝病患者的姑息治疗咨询从2009年至2013年增加。
- 临终住院期间的姑息治疗咨询与较低的费用和操作负担相关。
- 未来研究应评估姑息治疗的时机及其对临终照护质量的影响。
研究设计与样本
- 横断面观察性研究,分析2009年至2013年全国住院患者样本中失代偿期肝硬化成人的临终住院数据。
主要发现
- 临终失代偿期肝硬化住院成人中30.3%接受姑息治疗,每次住院平均费用为48551±1142美元。
- 姑息治疗咨询逐年增加,2009年为18.0%,2013年为36.6%(P<.05)。
- 临终住院平均费用无显著增加(2009年47969美元至2013年48956美元,P=.77)。
- 非裔美国人、西班牙裔、亚裔及肝移植候选者接受姑息治疗的可能性较低,而大型城市教学医院照护与接受咨询的更高比值比相关。
- 调整其他因素后,姑息治疗与费用降低10062美元相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There has been increased attention on ways to improve the quality of end-of-life care for patients with end-stage liver disease; however, there have been few reports of care experiences for patients during terminal hospitalizations. We analyzed data from a large national database to increase our understanding of palliative care for and health care utilization by patients with end-stage liver disease. METHODS: We performed a cross-sectional, observational study to examine terminal hospitalizations of adults with decompensated cirrhosis using data from the National Inpatient Sample from 2009 through 2013. We collected data on palliative care consultation and total hospital costs, and performed multivariate regression analyses to identify factors associated with palliative care consultation. We also investigated whether consultation was associated with lower costs. RESULTS: Among hospitalized adults with terminal decompensated cirrhosis, 30.3% received palliative care; the mean cost per hospitalization was $48,551 ± $1142. Palliative care consultation increased annually, and was provided to 18.0% of patients in 2009 and to 36.6% of patients in 2013 (P < .05). The mean cost for the terminal hospitalization did not increase significantly ($47,969 in 2009 to $48,956 in 2013, P = .77). African Americans, Hispanics, Asians, and liver transplant candidates were less likely to receive palliative care, whereas care in large urban teaching hospitals was associated with a higher odds of receiving consultation. Palliative care was associated with lower procedure burden-after adjusting for other factors, palliative care was associated with a cost reduction of $10,062. CONCLUSIONS: Palliative care consultation for patients with end-stage liver disease increased from 2009 through 2013. Palliative care consultation during terminal hospitalizations is associated with lower costs and procedure burden. Future research should evaluate timing and effects of palliative care on quality of end-of-life care in this population.
引用
- Patel AA, Walling AM, Ricks-Oddie J, et al. Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life. Clin Gastroenterol Hepatol. 2017. PMID: 28179192. doi:10.1016/j.cgh.2017.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。